{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:27:29Z","timestamp":1790616449080,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K09310"],"award-info":[{"award-number":["18K09310"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H03082"],"award-info":[{"award-number":["21H03082"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02838"],"award-info":[{"award-number":["22H02838"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00262-023-03394-7","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T08:02:58Z","timestamp":1677052978000},"page":"2087-2098","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Expression of soluble CD27 in extranodal natural killer\/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27\/CD70-targeted therapy"],"prefix":"10.1007","volume":"72","author":[{"given":"Toshihiro","family":"Nagato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Komatsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Kishibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ohkuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Harabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihisa","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekiyo","family":"Yamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Wakisaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Hirata-Nozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Kumai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Katada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Harabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"3394_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9071381","author":"M Takahara","year":"2021","unstructured":"Takahara M, Kumai T, Kishibe K, Nagato T, Harabuchi Y (2021) Extranodal NK\/T-cell lymphoma, nasal type: genetic, biologic, and clinical aspects with a central focus on Epstein\u2013Barr virus relation. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms9071381","journal-title":"Microorganisms"},{"key":"3394_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.amjms.2020.03.012","volume":"360","author":"T Nagato","year":"2020","unstructured":"Nagato T, Takahara M, Harabuchi Y (2020) Ulcerated lesions of the midline gingiva and soft palate. Am J Med Sci 360:77. https:\/\/doi.org\/10.1016\/j.amjms.2020.03.012","journal-title":"Am J Med Sci"},{"key":"3394_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0140-6736(90)90002-m","volume":"335","author":"Y Harabuchi","year":"1990","unstructured":"Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T (1990) Epstein\u2013Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335:128\u2013130. https:\/\/doi.org\/10.1016\/0140-6736(90)90002-m","journal-title":"Lancet"},{"key":"3394_CR4","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2137::AID-CNCR27>3.0.CO;2-V","volume":"77","author":"Y Harabuchi","year":"1996","unstructured":"Harabuchi Y, Imai S, Wakashima J, Hirao M, Kataura A, Osato T, Kon S (1996) Nasal T-cell lymphoma causally associated with Epstein\u2013Barr virus: clinicopathologic, phenotypic, and genotypic studies. Cancer 77:2137\u20132149","journal-title":"Cancer"},{"key":"3394_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ijc.25969","volume":"130","author":"H Ishii","year":"2012","unstructured":"Ishii H, Takahara M, Nagato T, Kis LL, Nagy N, Kishibe K, Harabuchi Y, Klein E (2012) Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer\/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15. Int J Cancer 130:48\u201358. https:\/\/doi.org\/10.1002\/ijc.25969","journal-title":"Int J Cancer"},{"key":"3394_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.exphem.2013.03.009","volume":"41","author":"M Takahara","year":"2013","unstructured":"Takahara M, Nagato T, Komabayashi Y, Yoshino K, Ueda S, Kishibe K, Harabuchi Y (2013) Soluble ICAM-1 secretion and its functional role as an autocrine growth factor in nasal NK\/T cell lymphoma cells. Exp Hematol 41:711\u2013718. https:\/\/doi.org\/10.1016\/j.exphem.2013.03.009","journal-title":"Exp Hematol"},{"key":"3394_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ajh.23570","volume":"89","author":"Y Komabayashi","year":"2014","unstructured":"Komabayashi Y, Kishibe K, Nagato T, Ueda S, Takahara M, Harabuchi Y (2014) Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK\/T-cell lymphoma. Am J Hematol 89:25\u201333. https:\/\/doi.org\/10.1002\/ajh.23570","journal-title":"Am J Hematol"},{"key":"3394_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41374-018-0182-9","volume":"99","author":"T Nagato","year":"2019","unstructured":"Nagato T, Ueda S, Takahara M, Kishibe K, Komabayashi Y, Kumai T, Ohara K, Hirata-Nozaki Y, Harabuchi S, Hayashi R, Ohkuri T, Bernasconi M, Nadal D, Kobayashi H, Harabuchi Y (2019) Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer\/T-cell lymphoma. Lab Investig 99:612\u2013624. https:\/\/doi.org\/10.1038\/s41374-018-0182-9","journal-title":"Lab Investig"},{"key":"3394_CR9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00262-017-1987-x","volume":"66","author":"T Nagato","year":"2017","unstructured":"Nagato T, Ohkuri T, Ohara K, Hirata Y, Kishibe K, Komabayashi Y, Ueda S, Takahara M, Kumai T, Ishibashi K, Kosaka A, Aoki N, Oikawa K, Uno Y, Akiyama N, Sado M, Takei H, Celis E, Harabuchi Y, Kobayashi H (2017) Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer\/T-cell lymphoma: a potential rationale for immunotherapy. Cancer Immunol Immunother 66:877\u2013890. https:\/\/doi.org\/10.1007\/s00262-017-1987-x","journal-title":"Cancer Immunol Immunother"},{"key":"3394_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2015.07.007","volume":"155","author":"J Jacobs","year":"2015","unstructured":"Jacobs J, Deschoolmeester V, Zwaenepoel K, Rolfo C, Silence K, Rottey S, Lardon F, Smits E, Pauwels P (2015) CD70: an emerging target in cancer immunotherapy. Pharmacol Ther 155:1\u201310. https:\/\/doi.org\/10.1016\/j.pharmthera.2015.07.007","journal-title":"Pharmacol Ther"},{"key":"3394_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13046-021-02215-y","volume":"41","author":"T Flieswasser","year":"2022","unstructured":"Flieswasser T, Van den Eynde A, Van Audenaerde J, De Waele J, Lardon F, Riether C, de Haard H, Smits E, Pauwels P, Jacobs J (2022) The CD70\u2013CD27 axis in oncology: the new kids on the block. J Exp Clin Cancer Res 41:12. https:\/\/doi.org\/10.1186\/s13046-021-02215-y","journal-title":"J Exp Clin Cancer Res"},{"key":"3394_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nri2526","volume":"9","author":"M Croft","year":"2009","unstructured":"Croft M (2009) The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 9:271\u2013285. https:\/\/doi.org\/10.1038\/nri2526","journal-title":"Nat Rev Immunol"},{"key":"3394_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1600-065X.2009.00774.x","volume":"229","author":"MA Nolte","year":"2009","unstructured":"Nolte MA, van Olffen RW, van Gisbergen KP, van Lier RA (2009) Timing and tuning of CD27\u2013CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol Rev 229:216\u2013231. https:\/\/doi.org\/10.1111\/j.1600-065X.2009.00774.x","journal-title":"Immunol Rev"},{"key":"3394_CR14","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1158\/1078-0432.CCR-14-1425","volume":"21","author":"M Ruf","year":"2015","unstructured":"Ruf M, Mittmann C, Nowicka AM, Hartmann A, Hermanns T, Poyet C, van den Broek M, Sulser T, Moch H, Schraml P (2015) pVHL\/HIF-regulated CD70 expression is associated with infiltration of CD27+ lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinoma. Clin Cancer Res 21:889\u2013898. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-1425","journal-title":"Clin Cancer Res"},{"key":"3394_CR15","first-page":"2592","volume":"62","author":"J Wischhusen","year":"2002","unstructured":"Wischhusen J, Jung G, Radovanovic I, Beier C, Steinbach JP, Rimner A, Huang H, Schulz JB, Ohgaki H, Aguzzi A, Rammensee HG, Weller M (2002) Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma. Cancer Res 62:2592\u20132599","journal-title":"Cancer Res"},{"key":"3394_CR16","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.4049\/jimmunol.1300022","volume":"190","author":"J Huang","year":"2013","unstructured":"Huang J, Jochems C, Anderson AM, Talaie T, Jales A, Madan RA, Hodge JW, Tsang KY, Liewehr DJ, Steinberg SM, Gulley JL, Schlom J (2013) Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity. J Immunol 190:6250\u20136258. https:\/\/doi.org\/10.4049\/jimmunol.1300022","journal-title":"J Immunol"},{"key":"3394_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/bjh.12136","volume":"160","author":"K Yoshino","year":"2013","unstructured":"Yoshino K, Kishibe K, Nagato T, Ueda S, Komabayashi Y, Takahara M, Harabuchi Y (2013) Expression of CD70 in nasal natural killer\/T cell lymphoma cell lines and patients; its role for cell proliferation through binding to soluble CD27. Br J Haematol 160:331\u2013342. https:\/\/doi.org\/10.1111\/bjh.12136","journal-title":"Br J Haematol"},{"key":"3394_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/sj.thj.6200013","volume":"1","author":"NL Harris","year":"2000","unstructured":"Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (2000) The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting\u2014Airlie House, Virginia, November 1997. Hematol J 1:53\u201366. https:\/\/doi.org\/10.1038\/sj.thj.6200013","journal-title":"Hematol J"},{"key":"3394_CR19","doi-asserted-by":"publisher","first-page":"13462","DOI":"10.18632\/oncotarget.3880","volume":"6","author":"J Jacobs","year":"2015","unstructured":"Jacobs J, Zwaenepoel K, Rolfo C, Van den Bossche J, Deben C, Silence K, Hermans C, Smits E, Van Schil P, Lardon F, Deschoolmeester V, Pauwels P (2015) Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer. Oncotarget 6:13462\u201313475. https:\/\/doi.org\/10.18632\/oncotarget.3880","journal-title":"Oncotarget"},{"key":"3394_CR20","doi-asserted-by":"publisher","first-page":"8250","DOI":"10.1158\/1078-0432.CCR-05-1426","volume":"11","author":"T Nagato","year":"2005","unstructured":"Nagato T, Kobayashi H, Kishibe K, Takahara M, Ogino T, Ishii H, Oikawa K, Aoki N, Sato K, Kimura S, Shimizu N, Tateno M, Harabuchi Y (2005) Expression of interleukin-9 in nasal natural killer\/T-cell lymphoma cell lines and patients. Clin Cancer Res 11:8250\u20138257. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-1426","journal-title":"Clin Cancer Res"},{"key":"3394_CR21","doi-asserted-by":"publisher","first-page":"1856545","DOI":"10.1080\/2162402X.2020.1856545","volume":"10","author":"R Hayashi","year":"2020","unstructured":"Hayashi R, Nagato T, Kumai T, Ohara K, Ohara M, Ohkuri T, Hirata-Nozaki Y, Harabuchi S, Kosaka A, Nagata M, Yajima Y, Yasuda S, Oikawa K, Kono M, Kishibe K, Takahara M, Katada A, Hayashi T, Celis E, Harabuchi Y, Kobayashi H (2020) Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma. Oncoimmunology 10:1856545. https:\/\/doi.org\/10.1080\/2162402X.2020.1856545","journal-title":"Oncoimmunology"},{"key":"3394_CR22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00262-015-1675-7","volume":"64","author":"T Kumai","year":"2015","unstructured":"Kumai T, Nagato T, Kobayashi H, Komabayashi Y, Ueda S, Kishibe K, Ohkuri T, Takahara M, Celis E, Harabuchi Y (2015) CCL17 and CCL22\/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer\/T-cell lymphoma. Cancer Immunol Immunother 64:697\u2013705. https:\/\/doi.org\/10.1007\/s00262-015-1675-7","journal-title":"Cancer Immunol Immunother"},{"key":"3394_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF02899665","volume":"62","author":"G Niedobitek","year":"1992","unstructured":"Niedobitek G, Fahraeus R, Herbst H, Latza U, Ferszt A, Klein G, Stein H (1992) The Epstein\u2013Barr virus encoded membrane protein (LMP) induces phenotypic changes in epithelial cells. Virchows Arch B Cell Pathol Incl Mol Pathol 62:55\u201359. https:\/\/doi.org\/10.1007\/BF02899665","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"3394_CR24","doi-asserted-by":"publisher","first-page":"E686","DOI":"10.1073\/pnas.1713607115","volume":"115","author":"IK Choi","year":"2018","unstructured":"Choi IK, Wang Z, Ke Q, Hong M, Qian Y, Zhao X, Liu Y, Kim HJ, Ritz J, Cantor H, Rajewsky K, Wucherpfennig KW, Zhang B (2018) Signaling by the Epstein\u2013Barr virus LMP1 protein induces potent cytotoxic CD4(+) and CD8(+) T cell responses. Proc Natl Acad Sci U S A 115:E686\u2013E695. https:\/\/doi.org\/10.1073\/pnas.1713607115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3394_CR25","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1182\/blood.V82.11.3430.3430","volume":"82","author":"MH van Oers","year":"1993","unstructured":"van Oers MH, Pals ST, Evers LM, van der Schoot CE, Koopman G, Bonfrer JM, Hintzen RQ, von dem Borne AE, van Lier RA (1993) Expression and release of CD27 in human B-cell malignancies. Blood 82:3430\u20133436","journal-title":"Blood"},{"key":"3394_CR26","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.exphem.2005.10.005","volume":"33","author":"A Nilsson","year":"2005","unstructured":"Nilsson A, de Milito A, Mowafi F, Winberg G, Bjork O, Wolpert EZ, Chiodi F (2005) Expression of CD27\u2013CD70 on early B cell progenitors in the bone marrow: implication for diagnosis and therapy of childhood ALL. Exp Hematol 33:1500\u20131507. https:\/\/doi.org\/10.1016\/j.exphem.2005.10.005","journal-title":"Exp Hematol"},{"key":"3394_CR27","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1182\/blood-2007-04-084525","volume":"112","author":"AW Ho","year":"2008","unstructured":"Ho AW, Hatjiharissi E, Ciccarelli BT, Branagan AR, Hunter ZR, Leleu X, Tournilhac O, Xu L, O\u2019Connor K, Manning RJ, Santos DD, Chemaly M, Patterson CJ, Soumerai JD, Munshi NC, McEarchern JA, Law CL, Grewal IS, Treon SP (2008) CD27\u2013CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia. Blood 112:4683\u20134689. https:\/\/doi.org\/10.1182\/blood-2007-04-084525","journal-title":"Blood"},{"key":"3394_CR28","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/jmv.20853","volume":"79","author":"H Ishii","year":"2007","unstructured":"Ishii H, Ogino T, Berger C, Kochli-Schmitz N, Nagato T, Takahara M, Nadal D, Harabuchi Y (2007) Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK\/T-cell lymphoma. J Med Virol 79:562\u2013572. https:\/\/doi.org\/10.1002\/jmv.20853","journal-title":"J Med Virol"},{"key":"3394_CR29","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1182\/blood-2011-05-354142","volume":"118","author":"R Suzuki","year":"2011","unstructured":"Suzuki R, Yamaguchi M, Izutsu K, Yamamoto G, Takada K, Harabuchi Y, Isobe Y, Gomyo H, Koike T, Okamoto M, Hyo R, Suzumiya J, Nakamura S, Kawa K, Oshimi K, Group NK-cTS (2011) Prospective measurement of Epstein\u2013Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK\/T-cell lymphoma, nasal type. Blood 118:6018\u20136022. https:\/\/doi.org\/10.1182\/blood-2011-05-354142","journal-title":"Blood"},{"key":"3394_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000070661","volume":"24","author":"M Kok","year":"2003","unstructured":"Kok M, Bonfrer JM, Korse CM, de Jong D, Kersten MJ (2003) Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin\u2019s lymphoma. Tumour Biol 24:53\u201360. https:\/\/doi.org\/10.1159\/000070661","journal-title":"Tumour Biol"},{"key":"3394_CR31","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3109\/10428194.2012.660627","volume":"53","author":"N Goto","year":"2012","unstructured":"Goto N, Tsurumi H, Takemura M, Kanemura N, Kasahara S, Hara T, Yasuda I, Shimizu M, Yamada T, Sawada M, Takahashi T, Yamada T, Seishima M, Moriwaki H, Takami T (2012) Serum soluble CD27 level is associated with outcome in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone. Leuk Lymphoma 53:1494\u20131500. https:\/\/doi.org\/10.3109\/10428194.2012.660627","journal-title":"Leuk Lymphoma"},{"key":"3394_CR32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000502441","volume":"97","author":"J Kashima","year":"2019","unstructured":"Kashima J, Okuma Y, Hosomi Y, Hishima T (2019) High serum soluble CD27 level correlates with poor performance status and reduced survival in patients with advanced lung cancer. Oncology 97:365\u2013372. https:\/\/doi.org\/10.1159\/000502441","journal-title":"Oncology"},{"key":"3394_CR33","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1158\/0008-5472.CAN-12-0588","volume":"72","author":"QJ Wang","year":"2012","unstructured":"Wang QJ, Hanada K, Robbins PF, Li YF, Yang JC (2012) Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma. Cancer Res 72:6119\u20136129. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-0588","journal-title":"Cancer Res"},{"key":"3394_CR34","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.1158\/0008-5472.CAN-04-4395","volume":"65","author":"A Chahlavi","year":"2005","unstructured":"Chahlavi A, Rayman P, Richmond AL, Biswas K, Zhang R, Vogelbaum M, Tannenbaum C, Barnett G, Finke JH (2005) Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70. Cancer Res 65:5428\u20135438. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-4395","journal-title":"Cancer Res"},{"key":"3394_CR35","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1593\/neo.06451","volume":"8","author":"J Diegmann","year":"2006","unstructured":"Diegmann J, Junker K, Loncarevic IF, Michel S, Schimmel B, von Eggeling F (2006) Immune escape for renal cell carcinoma: CD70 mediates apoptosis in lymphocytes. Neoplasia 8:933\u2013938. https:\/\/doi.org\/10.1593\/neo.06451","journal-title":"Neoplasia"},{"key":"3394_CR36","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1038\/leu.2014.84","volume":"28","author":"ZZ Yang","year":"2014","unstructured":"Yang ZZ, Grote DM, Xiu B, Ziesmer SC, Price-Troska TL, Hodge LS, Yates DM, Novak AJ, Ansell SM (2014) TGF-beta upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin\u2019s lymphoma. Leukemia 28:1872\u20131884. https:\/\/doi.org\/10.1038\/leu.2014.84","journal-title":"Leukemia"},{"key":"3394_CR37","doi-asserted-by":"publisher","first-page":"19123","DOI":"10.18632\/oncotarget.24919","volume":"9","author":"S Kitajima","year":"2018","unstructured":"Kitajima S, Lee KL, Fujioka M, Sun W, You J, Chia GS, Wanibuchi H, Tomita S, Araki M, Kato H, Poellinger L (2018) Hypoxia-inducible factor-2 alpha up-regulates CD70 under hypoxia and enhances anchorage-independent growth and aggressiveness in cancer cells. Oncotarget 9:19123\u201319135. https:\/\/doi.org\/10.18632\/oncotarget.24919","journal-title":"Oncotarget"},{"key":"3394_CR38","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1158\/1535-7163.MCT-05-0253","volume":"4","author":"BF Israel","year":"2005","unstructured":"Israel BF, Gulley M, Elmore S, Ferrini S, Feng WH, Kenney SC (2005) Anti-CD70 antibodies: a potential treatment for EBV+ CD70-expressing lymphomas. Mol Cancer Ther 4:2037\u20132044. https:\/\/doi.org\/10.1158\/1535-7163.MCT-05-0253","journal-title":"Mol Cancer Ther"},{"key":"3394_CR39","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1128\/JVI.02013-07","volume":"82","author":"M Baba","year":"2008","unstructured":"Baba M, Okamoto M, Hamasaki T, Horai S, Wang X, Ito Y, Suda Y, Arima N (2008) Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells. J Virol 82:3843\u20133852. https:\/\/doi.org\/10.1128\/JVI.02013-07","journal-title":"J Virol"},{"key":"3394_CR40","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1182\/blood.2020010527","volume":"138","author":"P Balsas","year":"2021","unstructured":"Balsas P, Veloza L, Clot G, Sureda-Gomez M, Rodriguez ML, Masaoutis C, Frigola G, Navarro A, Bea S, Nadeu F, Gine E, Lopez-Guillermo A, Martinez A, Ribera-Cortada I, Engel P, Quintanilla-Martinez L, Klapper W, Campo E, Amador V (2021) SOX11, CD70, and Treg cells configure the tumor-immune microenvironment of aggressive mantle cell lymphoma. Blood 138:2202\u20132215. https:\/\/doi.org\/10.1182\/blood.2020010527","journal-title":"Blood"},{"key":"3394_CR41","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1126\/science.286.5438.300","volume":"286","author":"J Uchida","year":"1999","unstructured":"Uchida J, Yasui T, Takaoka-Shichijo Y, Muraoka M, Kulwichit W, Raab-Traub N, Kikutani H (1999) Mimicry of CD40 signals by Epstein\u2013Barr virus LMP1 in B lymphocyte responses. Science 286:300\u2013303. https:\/\/doi.org\/10.1126\/science.286.5438.300","journal-title":"Science"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-023-03394-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-023-03394-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-023-03394-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T12:03:49Z","timestamp":1686657829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-023-03394-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["3394"],"URL":"https:\/\/doi.org\/10.1007\/s00262-023-03394-7","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,22]]},"assertion":[{"value":"17 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in compliance with the principles of the Declaration of Helsinki and subsequent amendments, and the study protocol was approved by the Institutional Review Board of the Asahikawa Medical University (#1332\u20133).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent to participate and publish was obtained by the opt-out method on the Asahikawa Medical University website.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}